STOCK TITAN

[Form 4] RenovoRx, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Shaun Bagai, who serves as both Chief Executive Officer and a director of RenovoRx, Inc. (RNXT), reported two open-market purchases of the company's common stock in late August 2025. On 08/22/2025 he acquired 5,000 shares at $0.9495, increasing his beneficial holdings to 325,040 shares. On 08/25/2025 he purchased another 5,000 shares at $0.9098, bringing total reported holdings to 330,040 shares. The Form 4 was signed by Mr. Bagai on 08/26/2025 and expressly states these were open market purchases.

Shaun Bagai, amministratore delegato e membro del consiglio di amministrazione di RenovoRx, Inc. (RNXT), ha comunicato due acquisti sul mercato aperto delle azioni ordinarie della società alla fine di agosto 2025. In data 22/08/2025 ha acquisito 5.000 azioni a $0,9495, portando le sue partecipazioni utili a 325.040 azioni. In data 25/08/2025 ha comprato altre 5.000 azioni a $0,9098, salendo a un totale dichiarato di 330.040 azioni. Il modulo Form 4 è stato firmato da Mr. Bagai il 26/08/2025 e specifica che si trattava di acquisti sul mercato aperto.

Shaun Bagai, que se desempeña como director ejecutivo y miembro de la junta de RenovoRx, Inc. (RNXT), informó dos compras en el mercado abierto de acciones ordinarias de la compañía a finales de agosto de 2025. El 22/08/2025 adquirió 5.000 acciones a $0,9495, elevando sus participaciones beneficiarias a 325.040 acciones. El 25/08/2025 compró otras 5.000 acciones a $0,9098, alcanzando un total informado de 330.040 acciones. El Formulario 4 fue firmado por el Sr. Bagai el 26/08/2025 y declara expresamente que se trató de compras en el mercado abierto.

숀 바가이(Shaun Bagai)는 RenovoRx, Inc. (RNXT)의 최고경영자이자 이사로서 2025년 8월 말 회사 보통주를 장외가 아닌 공개 시장에서 두 차례 매수한 사실을 보고했습니다. 2025-08-225,000주를 주당 $0.9495에 매입하여 실질 보유주식이 325,040주로 늘었습니다. 2025-08-25에 추가로 5,000주를 주당 $0.9098에 매수해 총 신고 보유액은 330,040주가 되었습니다. Form 4는 2025-08-26에 바가이 씨가 서명했으며, 해당 거래가 공개 시장 매수(open market purchases)였음을 명시하고 있습니다.

Shaun Bagai, qui est à la fois directeur général et administrateur de RenovoRx, Inc. (RNXT), a déclaré deux achats d'actions ordinaires effectués sur le marché ouvert à la fin août 2025. Le 22/08/2025, il a acquis 5 000 actions à $0,9495, portant ses avoirs bénéficiaires à 325 040 actions. Le 25/08/2025, il a acheté 5 000 actions supplémentaires à $0,9098, portant le total déclaré à 330 040 actions. Le formulaire Form 4 a été signé par M. Bagai le 26/08/2025 et précise expressément qu'il s'agissait d'achats sur le marché ouvert.

Shaun Bagai, der als Chief Executive Officer und Direktor von RenovoRx, Inc. (RNXT) fungiert, meldete Ende August 2025 zwei Käufe von Stammaktien am offenen Markt. Am 22.08.2025 erwarb er 5.000 Aktien zu $0,9495 und erhöhte damit seine wirtschaftlichen Beteiligungen auf 325.040 Aktien. Am 25.08.2025 kaufte er weitere 5.000 Aktien zu $0,9098, womit die gemeldeten Gesamtbestände 330.040 Aktien betrugen. Das Formblatt Form 4 wurde von Herrn Bagai am 26.08.2025 unterzeichnet und weist ausdrücklich aus, dass es sich um Käufe am offenen Markt handelte.

Positive
  • CEO purchased shares on the open market, adding 10,000 shares across two transactions, which increases his reported direct ownership to 330,040 shares.
  • Form 4 disclosure appears complete with transaction dates, prices, amounts, ownership post-transaction, and a signature dated 08/26/2025.
Negative
  • None.

Insights

TL;DR Insider purchases by the CEO totaling 10,000 shares were executed on the open market at roughly $0.91–$0.95 per share.

The transactions show the CEO increased direct ownership to 330,040 shares through two modest open-market buys on 08/22/2025 and 08/25/2025. The filing discloses prices and post-transaction share counts but provides no information on total outstanding shares or the dollar value relative to his overall holdings, limiting assessment of materiality. These purchases are factual signals of insider activity but, standing alone, do not quantify their impact on valuation or control.

TL;DR CEO and director reported routine open-market purchases, properly disclosed on Form 4 and signed on 08/26/2025.

The Form 4 indicates compliance with Section 16 reporting: Mr. Bagai disclosed two purchases, specified transaction codes, prices, and updated beneficial ownership. The explanatory note states these were open-market purchases. The filing contains no indications of 10b5-1 plan use, pledging, or derivative activity. From a governance perspective, the disclosure is complete for the reported transactions but lacks contextual details (e.g., intent or funding source) which are not required on Form 4.

Shaun Bagai, amministratore delegato e membro del consiglio di amministrazione di RenovoRx, Inc. (RNXT), ha comunicato due acquisti sul mercato aperto delle azioni ordinarie della società alla fine di agosto 2025. In data 22/08/2025 ha acquisito 5.000 azioni a $0,9495, portando le sue partecipazioni utili a 325.040 azioni. In data 25/08/2025 ha comprato altre 5.000 azioni a $0,9098, salendo a un totale dichiarato di 330.040 azioni. Il modulo Form 4 è stato firmato da Mr. Bagai il 26/08/2025 e specifica che si trattava di acquisti sul mercato aperto.

Shaun Bagai, que se desempeña como director ejecutivo y miembro de la junta de RenovoRx, Inc. (RNXT), informó dos compras en el mercado abierto de acciones ordinarias de la compañía a finales de agosto de 2025. El 22/08/2025 adquirió 5.000 acciones a $0,9495, elevando sus participaciones beneficiarias a 325.040 acciones. El 25/08/2025 compró otras 5.000 acciones a $0,9098, alcanzando un total informado de 330.040 acciones. El Formulario 4 fue firmado por el Sr. Bagai el 26/08/2025 y declara expresamente que se trató de compras en el mercado abierto.

숀 바가이(Shaun Bagai)는 RenovoRx, Inc. (RNXT)의 최고경영자이자 이사로서 2025년 8월 말 회사 보통주를 장외가 아닌 공개 시장에서 두 차례 매수한 사실을 보고했습니다. 2025-08-225,000주를 주당 $0.9495에 매입하여 실질 보유주식이 325,040주로 늘었습니다. 2025-08-25에 추가로 5,000주를 주당 $0.9098에 매수해 총 신고 보유액은 330,040주가 되었습니다. Form 4는 2025-08-26에 바가이 씨가 서명했으며, 해당 거래가 공개 시장 매수(open market purchases)였음을 명시하고 있습니다.

Shaun Bagai, qui est à la fois directeur général et administrateur de RenovoRx, Inc. (RNXT), a déclaré deux achats d'actions ordinaires effectués sur le marché ouvert à la fin août 2025. Le 22/08/2025, il a acquis 5 000 actions à $0,9495, portant ses avoirs bénéficiaires à 325 040 actions. Le 25/08/2025, il a acheté 5 000 actions supplémentaires à $0,9098, portant le total déclaré à 330 040 actions. Le formulaire Form 4 a été signé par M. Bagai le 26/08/2025 et précise expressément qu'il s'agissait d'achats sur le marché ouvert.

Shaun Bagai, der als Chief Executive Officer und Direktor von RenovoRx, Inc. (RNXT) fungiert, meldete Ende August 2025 zwei Käufe von Stammaktien am offenen Markt. Am 22.08.2025 erwarb er 5.000 Aktien zu $0,9495 und erhöhte damit seine wirtschaftlichen Beteiligungen auf 325.040 Aktien. Am 25.08.2025 kaufte er weitere 5.000 Aktien zu $0,9098, womit die gemeldeten Gesamtbestände 330.040 Aktien betrugen. Das Formblatt Form 4 wurde von Herrn Bagai am 26.08.2025 unterzeichnet und weist ausdrücklich aus, dass es sich um Käufe am offenen Markt handelte.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bagai Shaun

(Last) (First) (Middle)
C/O RENOVORX, INC.
2570 W EL CAMINO REAL, SUITE 320

(Street)
MOUNTAIN VIEW CA 94040

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RenovoRx, Inc. [ RNXT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/22/2025 P 5,000(1) A $0.9495 325,040 D
Common Stock 08/25/2025 P 5,000(1) A $0.9098 330,040 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects open market purchases of the Issuer's securities.
/s/ Shaun Bagai 08/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did RNXT CEO Shaun Bagai report on Form 4?

He reported two open-market purchases: 5,000 shares on 08/22/2025 at $0.9495 and 5,000 shares on 08/25/2025 at $0.9098.

How many RNXT shares does Shaun Bagai beneficially own after these transactions?

Following the reported purchases, his beneficial ownership is reported as 330,040 shares.

Were these purchases part of a 10b5-1 trading plan according to the filing?

No. The Form 4 notes these were open market purchases and does not indicate they were made pursuant to a 10b5-1 plan.

When was the Form 4 signed and filed by Shaun Bagai?

The Form 4 is signed by Shaun Bagai on 08/26/2025.

Do the transactions include any derivative securities or option exercises?

No. Table II for derivative securities contains no reported transactions; only common stock open-market purchases are disclosed.
Renovorx Inc

NASDAQ:RNXT

RNXT Rankings

RNXT Latest News

RNXT Latest SEC Filings

RNXT Stock Data

33.88M
32.43M
4.41%
24%
0.24%
Biotechnology
Pharmaceutical Preparations
Link
United States
MOUNTAIN VIEW